Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Industry Support & Quality Initiatives
How the ACR manages conflict-of-interest policies
Ethics Forum: Understanding the Challenges in Rheumatology Today
Understand the challenges in rheumatology today
REF President: Annual Giving Is the Foundation of Our Core Awards
Annual giving is a fundraising component of the ACR Research and Education Foundation’s (REF’s) comprehensive development plan—the other main sources being the Industry Roundtable and planned giving, otherwise known as The Legacy Society. What has always struck me about annual giving is the munificence of our donors. When it comes to annual giving, most donors are ACR members whose spirit of generosity makes it possible for the REF to fulfill its mission of advancing research and training to improve the health of people with rheumatic diseases.
Recent Study Improves Understanding of Preclinical Rheumatoid Arthritis
A study recently published in Arthritis Care & Research (AC&R) reveals a novel approach for the study of preclinical rheumatoid arthritis (RA). The investigators conducting the study sought to determine if these RA-related biomarkers could also be found in healthy subjects in order to investigate relationships between genetic and environmental factors and the presence of these biomarkers. Their goal is to study how these biomarkers evolve.
Leaders in Washington, D.C., Addresses Advocates for Arthritis Conference
This spring, 120 rheumatologists, rheumatology health professionals, and patient advocates travelled to Washington, D.C., for the ACR’s annual Advocates for Arthritis conference.
March Madness on the High Seas: Hoops and Healthcare as Bedfellows
Hoops and healthcare as bedfellows
When Lupus Research is a Family Affair
Following sisters of SLE patients may shed light on risk factors and progression of the disease
State-of-the-Art Clinical Symposium Sessions Available Through SessionSelect
Did a busy practice prevent you from getting to Chicago in April for the ACR’s 2010 State-of-the-Art Clinical Symposium? Still want the latest news and education in rheumatology? Or, did you attend the meeting and want to revisit some of your favorite sessions? Nineteen general-session presentations from the symposium are now available on ACR’s SessionSelect, allowing you to tailor your learning experience to your educational needs without leaving your home or office, saving time and money.
Health Professional Careers in Rheumatology Research
Robert McLean, DSc, MPH, is an assistant research scientist at the Hebrew SeniorLife Institute for Aging Research in Boston, and his primary research interests lie in the epidemiology of osteoporosis and related fractures. After working in epidemiology for over 10 years, Dr. McLean recently established himself as an independent investigator without significant prior research experience, thanks to the help of an REF research award designed specifically for early career investigators.
- « Previous Page
- 1
- …
- 221
- 222
- 223
- 224
- 225
- …
- 248
- Next Page »